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Rotarod testAbstract A series of novel 2-amino-5-chlorobenzophenone derivatives (3a–3g) were prepared by the
reactionof2-(chloroacetamido)-5-chlorobenzophenoneanddifferentanilinederivativesbybothconven-
tional and microwave methods and structures were conﬁrmed on the basis of their TLC, IR, 1H NMR
andCHNelemental studies. Out of the twomethods, microwavemethodswas found to give better yield.
All the synthesized compounds were subjected to physicochemical parameters determination for BBB
penetration through online software. The logP values of most of our test compounds indicate that test
compounds have the potential to be CNS active. The experimentally determined and calculated values
of logP are very much similar to values of logP calculated by the online software chemsilico and are
in the range required for goodCNS activity. The values of other physicochemical parameters likemolec-
ular weight, nON value, nOHNH value, n-violations and the number of rotatable bonds of all the test
compounds also liebetween the ranges that are required for goodBBBpenetration.Thecompoundswere
screened for the skeletal muscle relaxant activity and from the investigation, it is quite apparent that all
the 2-amino-5-chlorobenzophenone derivatives (3a–3g) possess signiﬁcant differences between control
groupand treatedgroup,P< 0.001.Among these2-amino-5-chlorobenzophenonederivatives, the com-
pound bearing o-toluidine as a substituent (3e) possesses the highest skeletal muscle relaxant activity.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
2-Aminobenzophenone derivatives are important compounds
in organic chemistry because of their application in heterocyclic
synthesis and medicines (Walsh, 1980). 2-Aminobenzophenone
has been used as startingmaterial for the synthesis of 1, 4-benzo-
diazepines (Sternbach et al., 1962), proquazone and amfenac as
anti-inﬂammatory agents (Coombs et al., 1973; Welstead et al.,
1979; Ottosen et al., 2003). It has also been used for the synthesis
of Peptidoaminobenzophenones, a novel class of ring open
derivatives of 1, 4-benzodiazepines, evaluated for Central Ner-
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1977; Hirai et al., 1980). 2-Aminobenzophenone derivatives
were also evaluated as antimitotic agents (Liou et al., 2002)
and a novel class of bradykinin B1 receptor antagonists with
excellent receptor occupancy in the CNS of hBK B1 transgenic
rats but not a substrate for P-glycoprotein (P-gp) mediated ef-
ﬂux and hence good brain penetration (Su et al., 2008). All these
drugs synthesized from 2-aminobenzophenones possess CNS
activity. 2-aminobenzophenone derivatives were considered to
be of our interest because they fulﬁll all the structure activity
requirements as the benzodiazepine contains. According to
SAR study rings A and C and substitutions at these rings and
the substitution at the amide nitrogen of ring B are important
for the activity of benzodiazepines as shown in Fig. 1. So it
was considered to be of interest to synthesize the 2-aminobenz-
ophenones derivatives having all the important pharmaco-
phores required for the CNS activity of benzodiazepines to
obtain drugs with high therapeutic index than diazepam. In this
2-amino-5-chlorobenzophenones are subjected to acetylation by
treatingwith chloroacetylchloride to obtain 2-chloroacetamido-
benzophenones which are then reacted with different aniline
derivatives in the presence of potassium carbonate and DMF
by conventional and microwave irradiation methods to obtain
different derivatives (Scheme 1).2. Materials and methods
2.1. Experimental
The melting points were determined on Veego-programmable
melting point apparatus (microprocessor based) and are
uncorrected. Proton (1H) nuclear magnetic resonance
(1H NMR) spectra were obtained using Brucker AC-400 F,
400 MHZ spectrometer and are reported in parts per million
(ppm), downﬁeld from tetramethylsilane (TMS) as internal
standard. The spin multiplicities are indicated by the symbols:
s (singlet), d (doublets), t (triplet), q (quartet), m (multiplet)
and br (broad). Infrared (IR) spectra were obtained withFigure 1 Important pharmacophorPerkin Elmer 882 Spectrum and RXI, FT-IR model using
potassium bromide pellets (in cm1). The ultraviolet spectra
were recorded on Shimadzu, UV-1800 spectrophotometer. Ele-
mental analyses were carried out on a Perkin–Elmer 2400
CHN elemental analyzer. Syntheses related to microwave irra-
diation were carried out in domestic LG little chef microwave
oven. Reactions were monitored and the homogeneity of the
products was checked by TLC which were prepared with silica
gel G and activated at 110 C for 30 min. The plates were
developed by exposure to iodine vapors. Anhydrous sodium
sulfate was utilized as drying agents. All solvents were dried
and freshly distilled prior to use according to standard
procedure.
2.2. Synthesis of 2-(chloroacetamido)-5-chlorobenzophenone
2.2.1. Conventional method
The syntheses of 2-amino-5-chlorobenzophenone and 2-(chlo-
roacetamido)-5-chlorobenzophenone were carried out by
literaturemethods (Sternbach et al., 1961, 1962). In thismethod,
2-amino-5-chlorobenzophenone (1) (1 mole) and chloroacetyl-
chloride (2 mole) in toluene was reﬂuxed for 2.5 h to expel most
of the formed hydrogen chloride. The solution was then cooled,
washed with ice cold dilute aqueous ammonia solution, dried
with anhydrous sodium sulfate, ﬁltered and concentrated in va-
cuo. The recrystallization of the crude residue from alcohol
afforded 82% of 2-(chloroacetamido)-5-chlorobenzophenone
(2); mp 119–122 C, lit. (Sternbach et al., 1961) 119–121 C.
2.2.2. Microwave irradiation method
A solution of 2-amino-5-chlorobenzophenone (1) (0.464 g,
2 mmole) and chloroacetylchloride (0.318 ml, 4 mmole) in tol-
uene (20.0 ml) was irradiated for 1 minute in a microwave oven
(360 W). The solution was then cooled, washed with ice cold
dilute aqueous ammonia solution, dried with anhydrous
sodium sulfate, ﬁltered and concentrated in vacuo. The
recrystallization of the crude residue from alcohol afforded
88% of 2-(chloroacetamido)-5-chlorobenzophenone (2); mp
118–120 C, lit. (Sternbach et al., 1961) 119–121 C.e of 1,4-benzodiazepine nucleus.
Scheme 1 Synthesis of 2-amino-5-chloro-benzophenone deriva-
tives (3a–3g)
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chlorobenzophenone derivatives (3a–3g)
2.3.1. Conventional method
2-Amino-5-chlorobenzophenone derivatives were prepared by
stirring the equimolar of 2-(chloroacetamido)-5-chlorobenzo-
phenone and different aniline derivatives in the presence of
double mole of potassium carbonate in a minimum quantity
of DMF at room temperature for 20–28 h. After that the reac-
tion mixture was poured into ice cold water and the solid prod-
uct thus separated was collected through ﬁltration.
2.3.2. Microwave irradiation method
A solution of the equimolar of 2-(chloroacetamido)-5-chloro-
benzophenone and different aniline derivatives in the presence
of double mole of potassium carbonate in a minimum quantity
of DMF was irradiated for 2–3 minutes in the microwave oven
(360 W). After that the reaction mixture was poured into ice
cold water and the solid product thus separated was collected
through ﬁltration. The crude solid product was recrystallized
from alcohol. The physical characteristics of the synthesized
compounds are given in Table 1 and the comparison of %
yield and time taken for synthesis by the conventional and
microwave method is given in Table 2.2.3.3. 2-(40-Chloroanilino)acetamido-5-chlorobenzophenone
(3a)
IR (KBr cm1): 3346 (Sec N–H str), 3100 (Aromatic C–H str),
2984 (Aliphatic C–H str), 1661 (C‚O str), 1487 (Aromatic
C‚C str), 1229 (C–N str) and 761 (C–Cl str) 1H NMR
(DMSO-d6 1d ppm): 4.19 (s, 2H, –COCH2N), 7.26–8.60 (m,
12H, Ar–H) and 11.46 (br s, 1H, –NHCOCH2–) Anal. Calcd.
for C21H16 N2O2Cl2: C, 63.17; H, 4.04; N, 7.02; Found: C,
63.07; H, 4.02; N, 7.09.
2.3.4. 2-(40-Nitroanilino)acetamido-5-chlorobenzophenone (3b)
1H NMR (CDCl3 1d ppm): 4.19 (s, 2H, –COCH2N), 7.26–
8.60(m, 12H, Ar–H) and 11.46 (br s, 1H, –NHCOCH2–) Anal.
Calcd. for C21H16 N3O4Cl: C, 61.54; H, 3.94; N, 10.25; Found:
C, 61.49; H, 3.98; N, 10.18.
2.3.5. 2-(40-Hydroxyanilino)acetamido-5-chlorobenzophenone
(3c)
IR (KBr cm1): 3277 (O–H str), 2921 (Aliphatic C–H str),
1654 (Amide C‚O str), 1510 (Aromatic C‚C str) and 1249
(C–N str) 1H NMR (CDCl3 1d ppm): 4.28 (s, 2H, –COCH2N),
6.3 (s, 1H, Ar–OH), 7.26–8.67 (m, 12H, Ar–H) and 11.25 (br s,
1H, –NHCOCH2–) Anal. Calcd. for C21H17 N2O3Cl: C, 66.23;
H, 4.50; N, 7.36; Found: C, 63.07; H, 4.02; N, 7.09.
2.3.6. 2-Anilinoacetamido-5-chlorobenzophenone (3d)
IR (KBr cm1): 3346 (Sec N–H str), 2984 (Aliphatic C–H str),
1661 (Amide C‚O str), 1487 (Aromatic C‚C str) and 1229
(C–N str) 1H NMR (CDCl3 1d ppm): 4.28 (s, 2H, –COCH2N),
7.26–8.67 (m, 13H, Ar–H) and 11.25 (br s, 1H, –NHCOCH2–)
Anal. Calcd. for C21H17 N2O2Cl: C, 69.14; H, 4.70; N, 7.68;
Found: C, 69.08; H, 4.74; N, 7.62.
2.3.7. 2-(20-Methylanilino)acetamido-5-chlorobenzophenone
(3e)
IR (KBr cm1): 3240 (Sec N–H str), 2929 (Aliphatic C–H str),
1700 (Ketonic C‚O str), 1634 (Amide C‚O str), 1515 (Aro-
matic C‚C str) and 1242 (C–N str) 1H NMR (CDCl3 1d
ppm): 2.35 (s, 3H, Ar–CH3), 4.73 (s, 2H, –COCH2N), 7.26–
8.69 (m, 12H, Ar–H) and 11.38 (br s, 1H, –NHCOCH2–) Anal.
Calcd. for C22H19 N2O2Cl: N, 7.39; Found: N, 7.45.
2.3.8. 2-(40-Aminobenzoyloxy)acetamido-5-chlorobenzophe-
none (3f)
IR (KBr cm1): 3473 and 3367 (Primary N–H str), 3240 (Sec
N–H str), 3056 (Aromatic C–H str), 2948 (Aliphatic C–H
str), 1701 (Ketonic C‚O str), 1643 (Amide C‚O str), 1515
(Aromatic C‚C str), 1242 (C–N str) and 1100 (C–O str) 1H
NMR (CDCl3 1d ppm): 4.32 (s, 2H, Ar–NH2), 5.20 (s, 2H, –
COCH2N), 7.17–7.56 (m, 12H, Ar–H) and 9.68 (br s, 1H, –
NHCOCH2–) Anal. Calcd. for C21H17 N2O4Cl: N, 6.85;
Found: N, 6.79.
2.3.9. 2-Sulfanilamidoacetamido-5-chlorobenzophenone (3g)
IR (KBr cm1): 3481 and 3370 (Primary N–H str), 3265 (Sec
N–H str), 3056 (Aromatic C–H str), 2948 (Aliphatic C–H
str), 1710 (Ketonic C‚O str), 1665 (Amide C‚O str),
1520(Aromatic C‚C str), 1250 (C–N str) and 1100,1160 (C–
O str) 1H NMR (CDCl3 1d ppm): 4.12 (s, 2H, Ar–NH2),
4.57 (s, 2H, –COCH2N), 7.27–8.64 (m, 12H, Ar–H) and
11.26 (br s, 1H, –NHCOCH2–) Anal. Calcd. for C22H19
Table 1 Characterization data of synthesized compounds (3a–3g).
S. No. Compound Mp (C) Rf value Solvent system
1 3a 92–94 0.735 Toluene: ethyl acetate (9:1)
2 3b 131–134 0.729 Toluene: ethyl acetate (9:1)
3 3c 101–104 0.816 Chloroform
4 3d 114–117 0.724 Ethyl acetate
5 3e 118–120 0.821 Chloroform
6 3f 130–132 0.634 Ethyl acetate
7 3g 230–234 0.623 Ethyl acetate
Table 2 Comparison of % yield and time taken by compounds from both methods.
S. No. Compound Conventional Microwave
Yield (%) Time (h) Yield (%) Time (min)
1 3a 42 20 75 2
2 3b 27 24 58 2
3 3c 24 28 55 3
4 3d 34 24 65 2.5
5 3e 59 26 80 2.5
6 3f 63 28 83 3
7 3g 28 24 56 2
Table 4 Partition coefﬁcient values experimental values vs calculated value.
S. No. Compound miLogPa CSlogPb C logPc Observed logP (experimental)
1 3a 5.705 4.24 4.24 4.40
2 3b 4.986 3.678 1.78 4.68
3 3c 4.548 3.24 2.27 3.50
4 3d 5.027 3.91 3.064 4.24
5 3e 5.428 3.94 3.277 3.63
6 3f 4.938 4.664 3.306 4.78
7 3g 3.314 3.04 1.03 3.24
a www.molinspiration.com/cgi-bin/properties.
b www.chemsilico.com/cs_products/products.html.
c Moriguchi et al. (1992)
Table 3 Experimental logP values
S. No. Compound Abs. Conc. (lg/ml) Drug (mg) in distilled H2O Drug (mg) in n-octanol LogP=C(org)/C(aq)
1 3a 0.106 8.150 1.85 8.15 4.40
2 3b 0.160 8.242 1.76 8.24 4.68
3 3c 0.066 7.784 2.21 7.78 3.50
4 3d 0.585 8.091 1.91 8.09 4.24
5 3e 0.241 7.843 2.16 7.84 3.63
6 3f 0.255 8.270 1.73 8.27 4.78
7 3g 0.062 7.640 2.36 7.64 3.24
310 R.K. Singh et al.N2O2Cl: C, 69.75; H, 5.05; N, 7.39; Found: C, 69.69; H, 5.09;
N, 7.44.
2.4. Physicochemical evaluation
Target compounds were designed to be CNS active, hence the
parameters were selected which effect blood-brain barrier
(BBB). Lipophilicity is an important aspect of transport anddistribution of drugs in biological systems. The level of drug
lipophilicity is estimated by the partition coefﬁcient. Lipophil-
icity was the ﬁrst of the descriptors to be identiﬁed as impor-
tant for CNS penetration. Partition coefﬁcient (logP)
determination is done by shake-ﬂask method and by computa-
tional methods. To access whether test compounds have poten-
tial are likely to be permeate BBB, several computational
methods are available. The logP value of all the test
Table 5 Physicochemical parameters values.a
S. No. Compound M.W nON value nOHNH value n-Violations Rotatable bonds
1 3a 399.277 4 2 1 6
2 3b 409.829 7 2 0 7
3 3c 380.831 5 3 0 6
4 3d 364.832 4 2 1 6
5 3e 378.859 4 2 1 6
6 3f 408.841 6 3 1 6
7 3g 443.912 7 4 0 7
a www.molinspiration.com/cgi-bin/properties.
Table 6 Skeletal muscle relaxant activity by Rotarod test.
S. No. Treatment Dose Rotarod Test
1 CMC (Control) 4 ml/kg 2.45 ± 1.2
2 Diazepm (Standard) 4 mg/kg 69.70 ± 3.3*
3 3a 10 mg/kg 18.95 ± 13.2*
4 3b 10 mg/kg 18.83 ± 3.7*
5 3c 10 mg/kg 53.57 ± 3.5*
6 3d 10 mg/kg 29.66 ± 7.0*
7 3e 10 mg/kg 28.53 ± 10.2*
8 3f 10 mg/kg 55.16 ± 2.5*
9 3g 10 mg/kg 39.19 ± 8.2*
Data are mean ± SEM; (n= 5); P< 0.001 followed by ANOVA.
* Signiﬁcant difference between control group and treated group.
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mined experimentally and computed through online softwares
(www.molinspiration.com/cgi-bin/properties, xxxx). Other
physicochemical parameters like molecular weight, nON value,
nOHNH value, n-violations and number of rotatable bonds
are determined through online software. (www.chemsili-
co.com/cs_products/products.html., xxxx) Results are shown
in Table 4 and 5.
2.4.1. Experimental determination of partition coefﬁcient of 2-
amino-benzophenone derivatives (3a–3g)
Partition coefﬁcient was determined in between n-octanol and
distilled water using a modiﬁed procedure based on the meth-
od of Fugita et al. (1964). Standard plot of compounds (3a–3g)
were prepared in n-octanol. Various standard solutions of con-
centrations 0, 4, 8, 12 and 16 lg/ml were prepared from a stock
solution (100 lg/ml) of compounds (3a–3g) in kmax 341, 345,
235, 339, 333, 328, 341 nm respectively. Accurately weighed
quantity of compounds (10 mg) was taken in glass stopper
tubes containing equal volumes (50 ml) of distilled water and
n-octanol. The tubes were shaken for 6 h using water bath sha-
ker. After 24 h, the organic phase was separated with the help
of a separating funnel. The absorbance was measured on UV
spectrophotometer at appropriate wavelength after making
dilution to10 lg/ml. Results are shown in Table 3.
2.5. Skeletal muscle relaxant activity
(Kulkarni, 1993) The biological evaluation of eight synthesized
compounds for skeletal muscle relaxant activity was carried
out by Rotarod test. Diazepam was used as a standard drug.
Albino mice weighing (20–25 g) were used for the study.
Animals were housed under standard conditions and allowed
free access to both food and water ad libitum.
The experimental protocols were approved by Institutional
Animal Ethics Committee and a written permission from in
house ethics committee has been taken to carry out (Reference
no. 1080/C/07/CPCSEA on dated 03-April-2010) and com-
plete this study.
2.6. Rotarod test
Mice were placed on a horizontal wooden rod rotating at a
speed of 25 rpm. The mice capable of remaining on the top
for 1 min or more, in three successive trials were selected for
the study. The selected animals were divided into ten groups
(n= 5). The stock solutions of all the test samples and stan-
dard were prepared by suspending in 1% w/v carboxy methylcellulose. Carboxy methyl cellulose (4 ml/kg) and diazepam
(4 mg/kg) were given to group 1 and 2. Test sample 10 mg/
kg was injected into group 3. Each group of animals was then
placed on the rod at an interval of 30 min. The animals that
failed more than once on the Rotarod for 1 min were consid-
ered as passed the test.
2.7. Statistical analysis
The mean value ± SEM was calculated for each parameter.
The results were analyzed statistically by ANOVA and signif-
icant difference was found between control group and treated
group, P< 0.001. The results of experiments by proper statis-
tical analysis are tabulated in Table 6.
3. Results and discussion
We describe herein the synthesis of 2-Amino-5-chlorobenzo-
phenone derivatives, (3a–3g) by conventional and microwave
methods. For the synthesis of target compounds, ﬁrst, the
2-(chloroacetamido)-5-chlorobenzophenone (2) was prepared
by the conventional and microwave irradiation technique in
which 2-amino-5-chlorobenzophenone (1) and chloroacetyl-
chloride are treated in the presence of toluene. After that the
derivatives (3a–3g) were prepared by the reaction of 2-(chloro-
acetamido)-5-chlorobenzophenone (2) and different aniline
derivatives in the presence of potassium carbonate in a mini-
mum quantity of DMF with conventional and microwave
methods. It was observed that from both conventional and
microwave methods, the microwave method was found to give
the better yield. All the synthesized compounds (3a–3g) were
Figure 2 Graph of average %age decrease in time by Rotarod
test.
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ity of the synthesized compounds was checked by performing
TLC. The structures of the synthesized compounds were deter-
mined by their FTIR and 1H NMR. In accordance with the
data obtained from physicochemical evaluation studies
the logP values of most of our test compounds indicate that
the test compounds have the potential to be CNS active.
Experimentally determined values of logP of the test com-
pounds were less than 5. Calculated values of logP of the test
compounds were also less than 5. According to molinspiration,
the logP value of most of the test compounds was less than 5
except 3a, 3d and 3e and by chemsilico all the test compounds
have logP value less than 5. From all the above data it is
concluded that experimentally determined and calculated val-
ues of logP are very much similar to values of logP calculated
by the online software Chemsilico. According to the
rule of ﬁve, compounds with the number of violations not
more than 1 shows good bioavailability and bioactivity and
all the test compounds have the number of violations in the
range of 0–1. Compounds with nOHNH value (H-bond
donors) less than 5 show increased solubility in cellular
membranes and all the test compounds have nOHNH value
in the range of 2–4 which is less than 5. Compounds with
nON value (H-bond acceptors) less than 10 and molecular
weight less than 500 show good CNS activity and all the test
compounds have nON value in the range of 4–7 and molecular
weight in the range of 364.832–443.912. The number of rotat-
able bonds for CNS activity should not be more than 10 and
all the test compounds have the number of rotatable bonds
in the range of 6–7.
In accordance with the data obtained from skeletal muscle
relaxant activity, all the synthesized compounds have shown
signiﬁcant differences between control group and treated
group, P< 0.001, ANOVA. These results showed that com-
pounds have good muscle relaxant activity. As evidenced by
average %age decrease in time Fig. 2. Compound bearing sub-
stituents o-toluidine (3e) has shown the highest skeletal muscle
relaxant activity and compounds bearing substituents sulfanil-
amide (3 g), p-aminophenol (3c), p-aminobenzoic acid (3f) andaniline (3d) also possess good skeletal muscle relaxant activity
at dose (10 mg/kg).
4. Conclusion
In conclusion, a series of novel 2-Amino-5-chlorobenzophe-
none derivatives were prepared by both conventional and
microwave irradiation method. Microwave irradiation method
was found to give better yield. All the synthesized compounds
were subjected to physicochemical parameters determination
for BBB penetration through experimental and online soft-
ware. The compounds were screened for skeletal muscle relax-
ant activity and from the investigation, it is quite apparent that
all the 2-amino-5-chlorobenzophenone derivatives (3a–3g)
possess skeletal muscle relaxant activity.Acknowledgements
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